How does the Precision Peptide Genetic Test inform semaglutide dosing decisions
al (2018) Sugar-sweetened beverage intake and serum testosterone levels in adult males 2039 years old in the United States Bhasin, S
The accumulation of Gb3 was decreased in a dose-dependent manner after ERT, although accumulation of Gb3 remained after ERT (Fig
, ,
Nature 434 , 907913 (2005)
Wegovy (semaglutide) is a GLP-1 receptor agonist that slows gastric emptying, potentially exacerbating pre-existing gastric conditions Common gastrointestinal side effects include nausea (44%), vomiting (24%), dyspepsia, abdominal pain, and constipation Gastritis is not listed as a recognised adverse effect in the UK Summary of Product Characteristics Patients with severe gastrointestinal disease or history of peptic ulcer disease should discuss risks with their prescriber before starting treatment Seek urgent medical advice for severe abdominal pain, vomiting blood, black stools, or persistent symptoms that do not improve Table of Contents Can Wegovy Cause Gastritis
